Open AccessThis article is
- freely available
From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules
Department of Biology, Faculty of Sciences, Arak University, Iran
Laboratory of Chemical Biology, Institut de Science et d'Ingénierie Supramoléculaires; ISIS/Université de Strasbourg, CNRS-UMR 7006, 8, allée Gaspard Monge, BP 70028, F-67083, Strasbourg Cedex, France
Laboratoire de Biophysicochimie des Récepteurs Canaux, UMR 7199 “Conception et Application de Molécules Bioactives” CNRS-Université de Strasbourg, 74 Route du Rhin-BP 60024, 67401 Illkirch Cedex, France
* Author to whom correspondence should be addressed.
Received: 8 November 2010; in revised form: 1 February 2011 / Accepted: 16 March 2011 / Published: 21 March 2011
Abstract: Ligand-gated ion channels (LGIC) play a central role in inter-cellular communication. This key function has two consequences: (i) these receptor channels are major targets for drug discovery because of their potential involvement in numerous human brain diseases; (ii) they are often found to be the target of plant and animal toxins. Together this makes toxin/receptor interactions important to drug discovery projects. Therefore, toxins acting on LGIC are presented and their current/potential therapeutic uses highlighted.
Keywords: nAChR; P2X; GABA; Glycine; Serotonin; NMDA; AMPA; Kainate
Citations to this Article
Cite This Article
MDPI and ACS Style
Nasiripourdori, A.; Taly, V.; Grutter, T.; Taly, A. From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules. Toxins 2011, 3, 260-293.
Nasiripourdori A, Taly V, Grutter T, Taly A. From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules. Toxins. 2011; 3(3):260-293.
Nasiripourdori, Adak; Taly, Valérie; Grutter, Thomas; Taly, Antoine. 2011. "From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules." Toxins 3, no. 3: 260-293.